AntibodyDesignBFN: High-Fidelity Fixed-Backbone Antibody Design via Discrete Bayesian Flow Networks
Yue Hu, Feng Tao, Junqing Wang, YingChao Liu

TL;DR
AntibodyDesignBFN introduces a novel discrete Bayesian flow network framework for fixed-backbone antibody design, achieving high accuracy and efficiency by integrating geometric gradients and probabilistic modeling.
Contribution
This work presents the first application of Discrete Bayesian Flow Networks to antibody design, enabling high-fidelity, fast, and differentiable sequence generation conditioned on geometry.
Findings
Achieved 67.8% amino acid recovery rate on a 2025 test set.
Outperformed existing graph-based baselines in antibody sequence prediction.
Enabled millisecond inference on standard hardware.
Abstract
The computational design of antibodies with high specificity and affinity is a cornerstone of modern therapeutic development. While deep generative models have demonstrated potential, they often struggle to balance high-fidelity geometric conditioning with the discrete nature of amino acid sequences. In this work, we present AntibodyDesignBFN, a novel framework for fixed-backbone antibody design based on Discrete Bayesian Flow Networks (BFN). Unlike standard diffusion models, BFNs operate on a continuous probability simplex, enabling a fully differentiable generative process that seamlessly integrates geometric gradients. By combining a lightweight Geometric Transformer with Invariant Point Attention (IPA) and a resource-efficient training strategy, our model establishes a new state-of-the-art. Evaluations on a rigorous 2025 temporal test set (43 complexes) demonstrate that…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMonoclonal and Polyclonal Antibodies Research · Protein purification and stability · vaccines and immunoinformatics approaches
